585 related articles for article (PubMed ID: 23676106)
81. Randomised controlled trial to study the efficacy of exercise with and without metformin on women with polycystic ovary syndrome.
Tiwari N; Pasrija S; Jain S
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():149-154. PubMed ID: 30690191
[TBL] [Abstract][Full Text] [Related]
82. Association of lipid profile and obesity in patients with polycystic ovary syndrome.
Parveen S; Khan S; Khan MM; Gupta B; Ahmad A; Alam R
Endocr Regul; 2024 Jan; 58(1):83-90. PubMed ID: 38656255
[No Abstract] [Full Text] [Related]
83. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
Sahin S; Eroglu M; Selcuk S; Turkgeldi L; Kozali S; Davutoglu S; Muhcu M
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2851-6. PubMed ID: 25339479
[TBL] [Abstract][Full Text] [Related]
84. Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
Rautio K; Tapanainen JS; Ruokonen A; Morin-Papunen LC
Eur J Endocrinol; 2005 Feb; 152(2):269-75. PubMed ID: 15745936
[TBL] [Abstract][Full Text] [Related]
85. The relationship between thyroid function and metabolic changes in Chinese women with polycystic ovary syndrome.
Yin D; Ruan X; Tian X; Du J; Zhao Y; Cui Y; Li Y; Mueck AO
Gynecol Endocrinol; 2017 Apr; 33(4):332-335. PubMed ID: 28051891
[TBL] [Abstract][Full Text] [Related]
86. Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
Tan S; Hahn S; Benson S; Dietz T; Lahner H; Moeller LC; Schmidt M; Elsenbruch S; Kimmig R; Mann K; Janssen OE
Eur J Endocrinol; 2007 Nov; 157(5):669-76. PubMed ID: 17984248
[TBL] [Abstract][Full Text] [Related]
87. Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin.
Glueck CJ; Moreira A; Goldenberg N; Sieve L; Wang P
Hum Reprod; 2003 Aug; 18(8):1618-25. PubMed ID: 12871871
[TBL] [Abstract][Full Text] [Related]
88. The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial.
Soldat-Stanković V; Popović-Pejičić S; Stanković S; Prtina A; Malešević G; Bjekić-Macut J; Livadas S; Ognjanović S; Mastorakos G; Micić D; Macut D
J Endocrinol Invest; 2022 Mar; 45(3):583-595. PubMed ID: 34665453
[TBL] [Abstract][Full Text] [Related]
89. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome.
Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J
Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018
[TBL] [Abstract][Full Text] [Related]
90. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.
Genazzani AD; Battaglia C; Malavasi B; Strucchi C; Tortolani F; Gamba O
Fertil Steril; 2004 Jan; 81(1):114-9. PubMed ID: 14711553
[TBL] [Abstract][Full Text] [Related]
91. Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial.
Li Y; Tan J; Wang Q; Duan C; Hu Y; Huang W
Fertil Steril; 2020 Jan; 113(1):197-204. PubMed ID: 31718828
[TBL] [Abstract][Full Text] [Related]
92. Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
Elkind-Hirsch KE; Paterson MS; Seidemann EL; Gutowski HC
Fertil Steril; 2017 Jan; 107(1):253-260.e1. PubMed ID: 28228317
[TBL] [Abstract][Full Text] [Related]
93. Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome.
Ebrahimi-Mamaghani M; Saghafi-Asl M; Pirouzpanah S; Aliasgharzadeh A; Aliashrafi S; Rezayi N; Mehrzad-Sadaghiani M
J Health Popul Nutr; 2015 Mar; 33(1):157-67. PubMed ID: 25995732
[TBL] [Abstract][Full Text] [Related]
94. [Efficacy and metabolic safety of long-term treatment with ethinyl oestradiol/cyproterone and desogestrel/ethinyl oestradiol tablets in women with polycystic ovary syndrome].
Zhang J; Su M; Xu L; Yang Z; Yin W; Nie Y; Qiao X; Cheng R; Ma Y
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):917-922. PubMed ID: 30187872
[TBL] [Abstract][Full Text] [Related]
95. [Impact on the lipid level of obesity of spleen deficiency and damp blockage complicated by hyperlipemia treated with warm needling therapy and auricular acupuncture].
Wang K; Liu Z; Xu B
Zhongguo Zhen Jiu; 2016 Mar; 36(3):225-30. PubMed ID: 27344822
[TBL] [Abstract][Full Text] [Related]
96. The impact of serum adropin and ischemia modified albumin levels based on BMI in PCOS.
Inal ZO; Erdem S; Gederet Y; Duran C; Kucukaydin Z; Kurku H; Sakarya DK
Endokrynol Pol; 2018; 69(2):135-141. PubMed ID: 29465156
[TBL] [Abstract][Full Text] [Related]
97. Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome.
Tarkun I; Cetinarslan B; Türemen E; Sahin T; Cantürk Z; Komsuoglu B
Eur J Endocrinol; 2005 Jul; 153(1):115-21. PubMed ID: 15994753
[TBL] [Abstract][Full Text] [Related]
98. Acupuncture or metformin to improve insulin resistance in women with polycystic ovary syndrome: study protocol of a combined multinational cross sectional case-control study and a randomised controlled trial.
Stener-Victorin E; Zhang H; Li R; Friden C; Li D; Wang W; Wang H; Chang C; Li S; Huo Z; Zhang H; Ji X; Linden-Hirschberg A; Qiao J
BMJ Open; 2019 Jan; 9(1):e024733. PubMed ID: 30612112
[TBL] [Abstract][Full Text] [Related]
99. [Effects on polycystic ovary syndrome of abdominal obesity treated with the dialing needling method at the abdomen].
Shen K; Shou Y; Zhang K
Zhongguo Zhen Jiu; 2018 Dec; 38(12):1273-6. PubMed ID: 30672214
[TBL] [Abstract][Full Text] [Related]
100. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome.
Yildizhan R; Kurdoglu M; Adali E; Kolusari A; Yildizhan B; Sahin HG; Kamaci M
Arch Gynecol Obstet; 2009 Oct; 280(4):559-63. PubMed ID: 19214546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
